MTOR and breast cancer: Furthermore, inhibition of the AKT/mTOR pathway by LY290042 or rapamycin treatment also impaired the effect of SPOCK1 upregulation on the cell cycle, proliferation and EMT process, verifying the effect of the AKT/mTOR pathway on SPOCK1-induced BC cell growth and metastasis.